Unintended consequences of co-payment regulations in Belgium: the case of atorvastatin
Verfasser: | |
---|---|
Dokumenttyp: | Artikel |
Erscheinungsdatum: | 2015 |
Reihe/Periodikum: | Journal of Pharmaceutical Policy and Practice, Vol 8, Iss sup1 (2015) |
Verlag/Hrsg.: |
Taylor & Francis Group
|
Schlagwörter: | Atorvastatin / Rosuvastatin / Sales Figure / Patent Expiry / Reference Price System / Therapeutics. Pharmacology / RM1-950 / Pharmacy and materia medica / RS1-441 |
Sprache: | Englisch |
Permalink: | https://search.fid-benelux.de/Record/base-28563897 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | https://doi.org/10.1186/2052-3211-8-S1-P1 |